AFT Pharmaceuticals Limited (ASX: AFP)

AFT Pharmaceuticals Revenue

AFT Pharmaceuticals had revenue of 86.71M NZD in the half year ending September 30, 2024, with 31.88% growth. This brings the company's revenue in the last twelve months to 198.51M, up 13.76% year-over-year. In the fiscal year ending March 31, 2024, AFT Pharmaceuticals had annual revenue of 195.41M with 24.75% growth.

• Revenue (ttm): 198.51M NZD
• Revenue Growth: +13.76%
• P/S Ratio: n/a
• Revenue / Employee: 1.80M NZD
• Employees: 110
• Market Cap: 275.23M AUD

Revenue Chart

* This company reports financials in NZD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	195.41M	38.77M	24.75%
Mar 31, 2023	156.64M	26.33M	20.20%
Mar 31, 2022	130.31M	17.21M	15.22%
Mar 31, 2021	113.11M	7.51M	7.11%
Mar 31, 2020	105.60M	20.47M	24.05%